These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21305479)

  • 61. The need for large-scale randomized evidence without undue emphasis on small trials, meta-analyses, or subgroup analyses.
    Hennekens CH; Demets D
    JAMA; 2009 Dec; 302(21):2361-2. PubMed ID: 19952322
    [No Abstract]   [Full Text] [Related]  

  • 62. Key concepts in clinical epidemiology: detecting and dealing with heterogeneity in meta-analyses.
    Cordero CP; Dans AL
    J Clin Epidemiol; 2021 Feb; 130():149-151. PubMed ID: 33483004
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Developing the evidence base for cancer chemoprevention: use of meta-analysis.
    Nikolopoulos GK; Bagos PG; Bonovas S
    Curr Drug Targets; 2011 Dec; 12(13):1989-97. PubMed ID: 21158703
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Interpreting meta-analysis of continuous outcomes with pre and postvalues.
    Alahdab F; Zaiem F; Wang Z; Murad MH
    Evid Based Med; 2016 Aug; 21(4):139-40. PubMed ID: 27405599
    [No Abstract]   [Full Text] [Related]  

  • 65. EasyMA: a program for the meta-analysis of clinical trials.
    Cucherat M; Boissel JP; Leizorovicz A; Haugh MC
    Comput Methods Programs Biomed; 1997 Jul; 53(3):187-90. PubMed ID: 9230453
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Evidence-based cardiology: practical applications from epidemiology I. The evaluation of a novel drug or therapy].
    Trejo-Gutiérrez JF; López-Jiménez F
    Arch Cardiol Mex; 2011; 81(1):47-52. PubMed ID: 21592891
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Meta-analysis in cancer epidemiology.
    Morris RD
    Environ Health Perspect; 1994 Nov; 102 Suppl 8(Suppl 8):61-6. PubMed ID: 7851334
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Subgroup analyses: when should we believe them?
    Ghert M; Petrisor B
    J Bone Joint Surg Am; 2012 Jul; 94 Suppl 1():61-4. PubMed ID: 22810450
    [No Abstract]   [Full Text] [Related]  

  • 69. Reviews of the literature: expected standards.
    O'Malley L
    Community Dent Health; 2014 Mar; 31(1):2-3. PubMed ID: 24741885
    [No Abstract]   [Full Text] [Related]  

  • 70. Meta-analysis: some clinical and statistical contributions in several medical disciplines.
    Bartolucci AA
    Yonsei Med J; 2007 Apr; 48(2):157-63. PubMed ID: 17461511
    [TBL] [Abstract][Full Text] [Related]  

  • 71. (Mis-) Direction of effect sizes.
    Knittle KP
    Health Psychol; 2009 Sep; 28(5):647; author reply 647-8. PubMed ID: 19751093
    [No Abstract]   [Full Text] [Related]  

  • 72. Large-scale randomized evidence: large, simple trials and overviews of trials.
    Peto R; Collins R; Gray R
    J Clin Epidemiol; 1995 Jan; 48(1):23-40. PubMed ID: 7853045
    [No Abstract]   [Full Text] [Related]  

  • 73. Systematic overviews and meta-analyses in cardiology. Evidence-based cardiology. VIII.
    Avezum A
    Arq Bras Cardiol; 1999 Apr; 72(4):423-30. PubMed ID: 10531687
    [No Abstract]   [Full Text] [Related]  

  • 74. Comments on 'An exploratory test for an excess of significant findings' by JPA loannidis and TA Trikalinos.
    Johnson V; Yuan Y
    Clin Trials; 2007; 4(3):254-5; discussion 256-7. PubMed ID: 17715250
    [No Abstract]   [Full Text] [Related]  

  • 75. Meta-analysis: statistical alchemy for the 21st century.
    Feinstein AR
    J Clin Epidemiol; 1995 Jan; 48(1):71-9. PubMed ID: 7853050
    [No Abstract]   [Full Text] [Related]  

  • 76. Importance of meta-analysis and practical obstacles in oncological and epidemiological studies: statistics very close but also far!
    Tanriverdi O; Yeniceri N
    Asian Pac J Cancer Prev; 2015; 16(3):1303-6. PubMed ID: 25735371
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Application of credibility ceilings probes the robustness of meta-analyses of biomarkers and cancer risk.
    Papatheodorou SI; Tsilidis KK; Evangelou E; Ioannidis JP
    J Clin Epidemiol; 2015 Feb; 68(2):163-74. PubMed ID: 25433443
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Meta-analyses: what is heterogeneity?
    Sedgwick P
    BMJ; 2015 Mar; 350():h1435. PubMed ID: 25778910
    [No Abstract]   [Full Text] [Related]  

  • 79. Sensible use of observational clinical data.
    Overhage JM; Overhage LM
    Stat Methods Med Res; 2013 Feb; 22(1):7-13. PubMed ID: 21828172
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lessons from TGN1412 and TARGET: implications for observational studies and meta-analysis.
    Senn S
    Pharm Stat; 2008; 7(4):294-301. PubMed ID: 18381774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.